ATE222927T1 - Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii) - Google Patents
Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii)Info
- Publication number
- ATE222927T1 ATE222927T1 AT95301800T AT95301800T ATE222927T1 AT E222927 T1 ATE222927 T1 AT E222927T1 AT 95301800 T AT95301800 T AT 95301800T AT 95301800 T AT95301800 T AT 95301800T AT E222927 T1 ATE222927 T1 AT E222927T1
- Authority
- AT
- Austria
- Prior art keywords
- tcf
- monoclonal antibody
- monoclonal antibodies
- antibodies against
- against tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6074263A JPH07258298A (ja) | 1994-03-18 | 1994-03-18 | モノクローナル抗体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE222927T1 true ATE222927T1 (de) | 2002-09-15 |
Family
ID=13542077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95301800T ATE222927T1 (de) | 1994-03-18 | 1995-03-17 | Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii) |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5658742A (de) |
| EP (1) | EP0672685B1 (de) |
| JP (1) | JPH07258298A (de) |
| AT (1) | ATE222927T1 (de) |
| AU (1) | AU684132B2 (de) |
| CA (1) | CA2145005C (de) |
| DE (1) | DE69527868T2 (de) |
| DK (1) | DK0672685T3 (de) |
| ES (1) | ES2182867T3 (de) |
| NZ (1) | NZ270743A (de) |
| ZA (1) | ZA952125B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5821223A (en) * | 1990-09-14 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen |
| JP4006058B2 (ja) * | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
| ES2274567T3 (es) * | 1997-03-14 | 2007-05-16 | Daiichi Pharmaceutical Co., Ltd. | Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer. |
| US6548296B1 (en) | 1997-07-23 | 2003-04-15 | Roche Diagnostics Gmbh | Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| JP2003047470A (ja) * | 2001-08-01 | 2003-02-18 | Asahi Kasei Corp | 新規な抗体及びその用途 |
| US8575099B2 (en) * | 2006-04-20 | 2013-11-05 | Osaka University | Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0597A (ja) * | 1991-06-21 | 1993-01-08 | Snow Brand Milk Prod Co Ltd | 新規抗tcf−iiモノクローナル抗体及びそれを用いるtcf−iiの測定方法 |
-
1994
- 1994-03-18 JP JP6074263A patent/JPH07258298A/ja active Pending
-
1995
- 1995-03-15 ZA ZA952125A patent/ZA952125B/xx unknown
- 1995-03-15 US US08/404,643 patent/US5658742A/en not_active Expired - Lifetime
- 1995-03-17 AT AT95301800T patent/ATE222927T1/de not_active IP Right Cessation
- 1995-03-17 EP EP95301800A patent/EP0672685B1/de not_active Expired - Lifetime
- 1995-03-17 NZ NZ270743A patent/NZ270743A/en not_active IP Right Cessation
- 1995-03-17 AU AU14939/95A patent/AU684132B2/en not_active Ceased
- 1995-03-17 ES ES95301800T patent/ES2182867T3/es not_active Expired - Lifetime
- 1995-03-17 DK DK95301800T patent/DK0672685T3/da active
- 1995-03-17 DE DE69527868T patent/DE69527868T2/de not_active Expired - Fee Related
- 1995-03-20 CA CA002145005A patent/CA2145005C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0672685B1 (de) | 2002-08-28 |
| AU1493995A (en) | 1995-09-28 |
| CA2145005C (en) | 2005-06-21 |
| ES2182867T3 (es) | 2003-03-16 |
| EP0672685A2 (de) | 1995-09-20 |
| AU684132B2 (en) | 1997-12-04 |
| NZ270743A (en) | 1996-06-25 |
| US5658742A (en) | 1997-08-19 |
| ZA952125B (en) | 1995-12-14 |
| DE69527868T2 (de) | 2003-05-08 |
| JPH07258298A (ja) | 1995-10-09 |
| EP0672685A3 (de) | 1997-01-15 |
| DE69527868D1 (de) | 2002-10-02 |
| CA2145005A1 (en) | 1995-09-19 |
| DK0672685T3 (da) | 2003-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1759709T3 (da) | Humaniserede antistoffer mod leukocytadhæsionsmolekyle VLA-4 | |
| ATE208820T1 (de) | Humanisierte antikoerper | |
| EP0746398A4 (de) | Antikörperreinigung | |
| PT733069E (pt) | Antigenios ctla-8 de primata purificados e reagentes relacionados | |
| AP2000001786A0 (en) | Therapeutic uses of quinoline derivatives. | |
| DK0713495T3 (da) | Fremgangsmåder til forstærkning af den biologiske aktivitet af chemokiner | |
| DK388384D0 (da) | Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse | |
| BG101024A (bg) | Моноклонално антитяло срещу сd44v6 | |
| ZA946767B (en) | Monocional antibodies having property of causing apoptosis. | |
| ATE161582T1 (de) | Monoklonale antikörper der maus | |
| DE3482905D1 (de) | Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs. | |
| FI873553A7 (fi) | HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä | |
| GB9009106D0 (en) | Processes and intermediates for synthetic antibody derivatives | |
| DE69527868D1 (de) | Monoklonaler Antikörper gegen den tumorzytotoxischen Faktor II (TCF-II) | |
| FR2560212B1 (fr) | Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps | |
| ATE162553T1 (de) | Monoklonale antikörper gegen hepatitis-c-virus | |
| DK0513565T3 (da) | Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse | |
| DE3579808D1 (de) | Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung. | |
| ATE136469T1 (de) | Neue verwendung eines monoklonalen antikörpers | |
| IT8421612A0 (it) | Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |